US stock markets finished mixed on Wednesday, with the Dow and S&P 500 extending their recent rally into the seventh day and the Nasdaq finishing lower, as investors digested gloomy data and a long ...

Europe's Stoxx 600 index made gains for the seventh straight day on Wednesday amid a barrage of corporate earnings, after data pointed to stronger-than-expected GDP growth across the region.

London stocks extended their gains on Wednesday, after fresh data from the US showed a slowing in consumer price growth, ...

Analysts at Berenberg reiterated their 'buy' rating and 700.0p target price on makeup business Warpaint London on Wednesday, ...

The Gym Group revealed on Wednesday that chief executive Will Orr had acquired 14,385 ordinary shares in the London-listed fitness clubs operator.

Swiss pharma giant Novartis announced on Wednesday that it is to buy American clinical-stage biopharma firm Regulus for up to $1.7bn, bolstering its position in the renal disease treatment market.

Animal genetics company Genus surged after the US Food and Drug Administration (FDA) approved its PRP gene edit under its PRRS Resistant Pig ("PRP") programme for use in the U.S. food supply chain.

Results and updates from a collection of blue chips were causing major moves on the FTSE 100 on Wednesday, with Smith & Nephew, GSK and Coca-Cola HBC rising strongly, and Glencore, Taylor Wimpey and ...

March's personal consumption expenditures price index pointed to a softening in inflationary pressures across the US, ...

Major indices were in the red early on Wednesday after an advance estimate revealed the that US economy had contracted in ...

Profits at heavy equipment manufacturer Caterpillar fell in the first quarter as a result of weaker volumes and pricing.

US companies eased up on hiring in April as they tried to prepare themselves for impacts stemming from Donald Trump's so-called "Liberation Day" tariffs, according to ADP.